The FDA has recently approved intranasal ketamine brand name Spravato, the generic name is Eskatamine. This form of ketamine is given. Its very expensive compared to what we use at Infinity Life Center. Estimated first round of treatment is over 7000.00 which is much more than the intravenous ketamine which is around 4000.00 for the first round. For single doses the cost of Eskatmine is around 2000.00 while the intravenous form one treatment is 750.00 for depression. There is no generic form of Spravato.

How to Buy Esketamine Nasal Spray

At starlight-pharmacy.com, we are evaluating the intranasal form and are considering offering this to our patients. At present we are preparing to stock this drug for use with our patients who would prefer this technique. Yet we do recommend the intravenous drip as it is more standardized and more controlled. So until more experienced is obtained by more doctors we will withhold complete judgement with Spravato. Our medical director has been using Ketamine for over 35 years and has much experience with the drug with patients as anesthetic and used this drug for over 3 years to treat depression, chronic pain and PTSD with very good results.

Spravato (Esketamine Nasal Spray)

How Esketamine Works

Spravato is a medication used for the treatment of treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal ideation in adults. It contains ketamine, which is a form of ketamine, a dissociative anaesthetic.

The exact mechanism of how ketamine works to alleviate depression is not fully understood, but it is believed to involve the modulation of glutamate, an important neurotransmitter in the brain. By acting on the glutamate system, ketamine helps to restore synaptic connections and improve mood regulation in individuals with depression.

Side Effects of Spravato Esketamine

Disassociation (feeling disconnected from oneself or reality)
Dizziness
Sedation
Headache
Nausea
Increased blood pressure
Vomiting
Vertigo
Blurred vision

These side effects are typically mild to moderate in severity and may diminish with repeated doses. However, some individuals may experience more serious adverse reactions, so monitoring for any unusual symptoms and consulting a healthcare professional is essential.

Indications